Cellcept Suspension Powder 31.8% contains mycophenolate mofetil, an immunosuppressant used to prevent organ rejection in transplant patients. This formulation, providing 200 mg/mL (as an oral solution after suspension), has a YJ code of 3999017B1025 and is manufactured by Chugai Pharmaceutical.
Cellcept Suspension Powder 31.8%
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
